Fuyuan Pharmaceutical: Subsidiary’s drug registration certificate approved

Fuyuan Pharmaceutical announced that its wholly-owned subsidiary, Zhejiang Aisheng Pharmaceutical Co., Ltd., recently received the “Drug Registration Certificate” for Eicosapentaenoic Acid Ethyl Ester Soft Capsules from the National Medical Products Administration, approving the production of this medication.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin